We are live on
!
Find out more
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
ONCE
Delisted
ONCE was delisted on the 16th of December, 2019.
172 hedge funds and large institutions have $3.23B invested in Spark Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 50 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
56% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 18
28% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 50
26% more capital invested
Capital invested by funds: $2.57B → $3.23B (+$669M)
6% more funds holding
Funds holding: 162 → 172 (+10)
35% less call options, than puts
Call options by funds: $13.5M | Put options by funds: $20.8M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
172
Holders Change
+10
Holders Change %
+6.17%
% of All Funds
3.94%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
28
Increased
64
Reduced
50
Closed
18
Calls
$13.5M
Puts
$20.8M
Net Calls
-$7.26M
Net Calls Change
-$3.9M
Top Buyers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$68.9M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$24.4M |
| 3 |
D.E. Shaw & Co
New York
|
+$21.1M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$18.5M |
| 5 |
BlackRock
New York
|
+$17.7M |
